In this weeks episode, we break down these new treatments and therapies, and discuss what they mean for patients
Byetta was FDA-approved in 2005, Victoza was approved in 2010, and Saxenda was approved in 2014
The frequency typically depends on the reason you are receiving them we can discuss your health goals with you to personalise a treatment plan
Conner Mertens 06:26 So the discussion were kind of having right now is federally speaking, right
Patients consistently report reduced appetite, enhanced satiety, fewer cravings for high-calorie foods, increased physical activity energy, and improvements in critical health markers such as blood pressure, cholesterol, and glucose levels
For high-performing individuals who might engage in intense exercise, skip meals due to a packed schedule, or consume alcohol, the risk of blood sugar dropping too low can become more pronounced